Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Philips has become aware that affected mrx devices may exhibit the following behaviors (a b and/or c): a. in aed mode the mrx experiences difficulty interpreting pads ecg waveforms and may incorrectly analyze the waveform (potential for inappropriate therapy) or fail to analyze the waveform. b. in manual mode the user may have trouble interpreting the pads ecg waveform and determining whether or not to deliver therapy in addition the mrx may provide erroneous alarms (e.G. pvc/min high vtach asystole) or indicate an asystolic rhythm when paddles are not in patient contact. c. if cpr meter is in use users may not get an accurate impedance derived ventilation feedback.